Nicholas LaBella
Keine laufenden Positionen mehr
Profil
Nicholas A.
LaBella held several positions in the pharmaceutical industry, including Director of Regulatory Affairs at Lorex Pharmaceuticals, Vice President of Development & Regulatory Affairs at CardioKine, and Vice President of Operations at PharmaNet.
He also served as Chief Scientific Officer at Insmed, Vice President of Global Regulatory Affairs at Tarsa Therapeutics, and Chief Scientific Officer & Senior Vice President at ZyVersa Therapeutics.
LaBella received his undergraduate degree from the University of Connecticut and his graduate degree from Arnold & Marie Schwartz College of Pharmacy & Health Science.
Ehemalige bekannte Positionen von Nicholas LaBella
| Unternehmen | Position | Ende |
|---|---|---|
| ZYVERSA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 18.08.2023 |
Tarsa Therapeutics, Inc.
 Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | General Counsel | 01.11.2017 |
| INSMED INCORPORATED | Technik-/Wissenschafts-/F&E-Leiter | 05.10.2012 |
CardioKine, Inc.
 CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | General Counsel | 01.01.2009 |
PharmaNet, Inc.
 PharmaNet, Inc. Medical DistributorsDistribution Services PharmaNet, Inc. researches and develops new drugs and provides clinical development & consulting services. Its services include strategic planning, data management, bio-statistics, site management, study monitoring, protocol/CRF design, project management, information technology, quality control and assurance and regulatory affairs. The company was founded in 1996 by Jeffrey P. McMullen and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 01.01.2004 |
Ausbildung von Nicholas LaBella
| University of Connecticut | Undergraduate Degree |
| Arnold & Marie Schwartz College of Pharmacy & Health Science | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INSMED INCORPORATED | Health Technology |
| ZYVERSA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Novartis Pharmaceuticals UK Ltd.
 Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom. | Health Technology |
PharmaNet, Inc. (Pennsylvania)
 PharmaNet, Inc. (Pennsylvania) Miscellaneous Commercial ServicesCommercial Services Part of Syneos Health, Inc., PharmaNet, Inc. (Pennsylvania) is a company that specializes in late stages clinical drug development. The company is based in Essington, PA. PharmaNet, Inc. (Pennsylvania was acquired by PharmaNet, Inc., part of Syneos Health, Inc. from December 22, 2004 on August 03, 2001. | Commercial Services |
PharmaNet, Inc.
PharmaNet, Inc. Medical DistributorsDistribution Services PharmaNet, Inc. researches and develops new drugs and provides clinical development & consulting services. Its services include strategic planning, data management, bio-statistics, site management, study monitoring, protocol/CRF design, project management, information technology, quality control and assurance and regulatory affairs. The company was founded in 1996 by Jeffrey P. McMullen and is headquartered in Princeton, NJ. | Distribution Services |
CardioKine, Inc.
CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | Health Technology |
Lorex Pharmaceuticals
 Lorex Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Sanofi, Lorex Pharmaceuticals is an American company that manufactures pharmaceutical products. The company is located in the US. The company was founded in 1990. Lorex Pharmaceuticals was acquired by Sanofi from Monsanto Co. on May 01, 1998. | Health Technology |
